Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01187875 · ClinicalTrials.gov registry record · Early Phase 1

Resistant Starch and Satiety

A Early Phase 1 study, sponsored by University of Minnesota.

Completed
Registry status
Early Phase 1
Development phase
20
Enrollment target

NCT01187875: Completed Early Phase 1 study, sponsored by University of Minnesota.

NCT01187875 is a Early Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 20 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01187875, a Early Phase 1 study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
Early Phase 1
Development phase
20 participants
Enrollment target

Study Summary

Dietary fiber consumption may contribute to weight regulation by improving satiety. In an earlier study the investigators found that a muffin containing resistant starch was more effective than other fibers in altering satiety. The objective of this study is to determine if 2 resistant starches consumed in muffins alter satiety and whether a mixture of resistant starches is more effective than either alone in enhancing satiety.

Primary Outcome

Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).

Interventions

  • DIETARY_SUPPLEMENT Placebo- Fiber free control
  • DIETARY_SUPPLEMENT Hi-maize resistant starch 9g
  • DIETARY_SUPPLEMENT Novalose 330 resistant starch 9g
  • DIETARY_SUPPLEMENT 4.5g Hi-maize resistant starch and 4.5g Novalose 330

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2009-09
Est. Completion 2011-06
Phase Early Phase 1
University of Minnesota

966 total trials

What the finished NCT01187875 record still lists

NCT01187875 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (62% lower).

The record links to 0 conditions, and to 4 interventions - of which Placebo- Fiber free control is the first listed.

NCT01187875 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01187875 about?

NCT01187875 is a clinical study titled "Resistant Starch and Satiety". Dietary fiber consumption may contribute to weight regulation by improving satiety. In an earlier study the investigators found that a muffin containing resistant starch was more effective than other fibers in altering satiety. The objective of this study is to determine if 2 resistant starches cons...

What is the current status of trial NCT01187875?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2009-09. Estimated completion is 2011-06.

What interventions are being tested in trial NCT01187875?

The interventions under investigation include: Placebo- Fiber free control (DIETARY_SUPPLEMENT), Hi-maize resistant starch 9g (DIETARY_SUPPLEMENT), Novalose 330 resistant starch 9g (DIETARY_SUPPLEMENT), 4.5g Hi-maize resistant starch and 4.5g Novalose 330 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01187875?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01187875's enrollment target sits among peer trials

20 1157th of 2000 higher than 710 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01187875, the US trial registry maintained by the National Library of Medicine. NCT01187875 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.